Bruce G. Allen Investments’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.8K Sell
243
-4
-2% -$1.08K 0.04% 220
2025
Q4
$62K Sell
247
-9
-4% -$2.39K 0.04% 229
2025
Q3
$73.5K Sell
256
-2
-0.8% -$536 0.05% 206
2025
Q2
$67.7K Sell
258
-3
-1% -$731 0.05% 213
2025
Q1
$60.7K Sell
261
-3
-1% -$728 0.05% 214
2024
Q4
$60.5K Sell
264
-4
-1% -$918 0.05% 223
2024
Q3
$59.9K Buy
268
+9
+3% +$1.98K 0.05% 227
2024
Q2
$52.7K Sell
259
-14
-5% -$2.85K 0.04% 228
2024
Q1
$59.6K Buy
273
+9
+3% +$1.98K 0.05% 211
2023
Q4
$60K Buy
+264
New +$55.5K 0.05% 207

Other funds holding LH

Bruce G. Allen Investments's LH Position: Q1 2026 in Review

Bruce G. Allen Investments reduced its Labcorp (LH) stake by 1.6% in Q1 2026, selling an estimated $1.08K and leaving 243 shares worth $64.8K. The position accounts for 0.04% of the portfolio, ranked #220.

Bruce G. Allen Investments first reported a position in LH in Q4 2023 and has held it in 10 quarters since. The position peaked at $73.5K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Bruce G. Allen Investments held 243 shares of Labcorp worth $64.8K as of Q1 2026.
  • Bruce G. Allen Investments sold 4 Labcorp shares in Q1 2026, an estimated $1.08K.
  • Labcorp made up 0.04% of Bruce G. Allen Investments's portfolio in Q1 2026, its #220 holding.
  • Bruce G. Allen Investments first reported a position in Labcorp in Q4 2023 and has held it in 10 quarters since.
  • Bruce G. Allen Investments's Labcorp position peaked at $73.5K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.